[Basic and clinical evaluation of a new assay procedure "SCC RIABEAD" for estimation of squamous cell carcinoma related antigen].
We examined the efficacy of a new commercial assay procedure (SCC RIABEAD) for estimation of squamous cell carcinoma related antigen (SCC). Intraassay and interassay variance were 4.0-14.6% and 4.6-17.0% respectively. Recovery and dilution tests gave satisfactory results. The normal range was under the level of 1.63 ng/ml. The patients with uterine cervical cancer or squamous cell carcinoma of the lung showed high positive rates. The values of SCC measured by SCC RIABEAD were well-correlated to those by SCC RIAKIT. However, SCC RIABEAD showed lower values in low SCC level and higher values in high SCC level than SCC RIAKIT.
Kuwabara
Y
Y
Department of Radiology, Faculty of Medicine, Kyushu University, Fukuoka-shi, Japan.
Ichiya
Y
Y
Komiya
T
T
Otsuka
M
M
Miyake
Y
Y
Takeda
R
R
Masuda
K
K
D000328:Adult; D000951:Antigens, Neoplasm / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000276:immunology*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011863:Radioimmunoassay / Q000379:methods*; D011933:Reagent Kits, Diagnostic / Q000592:standards*; D002583:Uterine Cervical Neoplasms / Q000276:immunology
D000951:Antigens, Neoplasm; D011933:Reagent Kits, Diagnostic